COYA - Coya Therapeutics • Financials

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
12/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2023	6	-8	-	L	L	36	L	-33	-	-12	-1	38	-13	0	0	-	-
12/2024	4	-17	-	L	L	40	L	-38	-	-13	-0	16	-13	0	0	-	-
12/2025	8	-23	-	L	L	43	L	-47	-	-15	-1	20	-16	0	0	-	-

To see all financials—including updated, you must be Premium.